Physician Assistant · Philadelphia, PA
NPI
1770138877
Since 2019
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3400 Civic Center Blvd
Philadelphia, PA, 19104
Phone (215) 615-5858
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,314
214 services
Medicare patients, 2024
58
Average age 71
Drug cost, 2024
$3.3M
710 prescriptions
Company payments, 2025
$271
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Grace F Shyu was code 99214 (office e&m - established), 61 times for 30 patients. In total Grace F Shyu billed 214 services in 10 codes, and Medicare paid $9,314.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 61 | 30 | $66.78 | $4,074 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 57 | 19 | $11.33 | $646 |
| 99213 Office E&M - Established | Facility | 47 | 15 | $45.34 | $2,131 |
| 38222 Other Organ Systems | Facility | 28 | 22 | $49.52 | $1,387 |
By year: 2022 $7,782 for 131 services; 2023 $11K for 180 services; 2024 $9,314 for 214 services.
Medicare prescription drug claims, 2024
In 2024, the drug Grace F Shyu prescribed most often to Medicare patients was Acyclovir, with 88 prescriptions and refills. In total Grace F Shyu wrote 710 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 88 | 131 | 33 | $2,059 |
| Levofloxacin Generic | 53 | 62 | 30 | $931 |
| Bosulif Bosutinib | 26 | 26 | Under 11 | $294K |
| Jakafi Ruxolitinib Phosphate | 24 | 24 | Under 11 | $394K |
| Venclexta Venetoclax | 23 | 23 | 12 | $207K |
| Xospata Gilteritinib Fumarate | 21 | 21 | Under 11 | $310K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 20 | 42 | 11 | $85.29 |
| Eliquis Apixaban | 16 | 16 | Under 11 | $9,258 |
| Furosemide Generic | 16 | 28 | Under 11 | $36.43 |
| Idhifa Enasidenib Mesylate | 16 | 16 | Under 11 | $518K |
| Tretinoin Generic | 15 | 15 | Under 11 | $52K |
| Metoprolol Succinate Generic | 12 | 15 | Under 11 | $126 |
| Ondansetron Hcl Generic | 12 | 12 | Under 11 | $703 |
| Tibsovo Ivosidenib | 12 | 12 | Under 11 | $336K |
| Posaconazole Generic | 11 | 11 | Under 11 | $22K |
Brand drugs: 229 claims; generic drugs: 481 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Grace F Shyu $271 ($271 in general payments such as food, travel and fees) from 2 companies. The largest payer was Sanofi-Aventis U.S. LLC with $138.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.